ABSTRACT Fibroblast replication is regulated by exogenous signals provided by growth factors, mediators that interact with the target cell surface and signal the cell to proliferate . A useful model of growth regulation, the "dual control model," suggests that growth factors can be grouped either as competence factors or as progression factors, and that optimal replication of fibroblasts requires the presence of both types of growth factors . Although most growth factors are soluble mediators, recent studies have demonstrated that, for some cell types, the extracellular matrix can replace the requirement for a competence factor . Since fibronectin is an important constituent of the extracellular matrix that interacts with specific domains on the fibroblast surface, we examined the ability of fibronectin to act as a competence factor to promote the growth of human diploid fibroblasts. To accomplish this, fibronectins purified from two sources, human plasma and human alveolar macrophages, were tested for their ability to (a) stimulate fibroblast replication in serum-free medium containing characterized progression factors (insulin or alveolar macrophage-derived growth factor) ; (b) provide a growth-promoting signal early in G, . Fibronectin stimulated fibroblast replication in a closedependent manner in the presence of a fixed dose of a progression factor . Conversely, fibronectin conferred on previously unresponsive fibroblasts the ability to replicate in a closedependent manner when cultured with increasing amounts of a progression factor. Moreover, fibronectin signaled growth-arrested fibroblasts to traverse G,^-4 h closer to S phase. No differences were observed in the ability of plasma or macrophage fibronectins to provide a competence signal for fibroblast replication . Since fibronectin is a major component of the extracellular matrix, these observations suggest that it may provide at least one of the signals by which the matrix conveys the "competence" that permits fibroblasts to replicate in the presence of an appropriate progression signal.
a general principle, cells require a signal from both competence factors and progression factors to manifest an optimal replication rate.
Normal fibroblast replication requires, in addition to soluble factors, that the cells attach to an extracellular matrix (9) . Interestingly, studies by Gospodarowicz et al. (10) (11) (12) have suggeted that, in addition to providing attachment sites for cells, the extracellular matrix can, at least for some cells, act to replace the requirement for growth factors such as fibroblast growth factor or platelet-derived growth factor. Since both fibroblast growth factor and platelet-derived growth factor are competence factors, these observations suggest that the overall requirements for fibroblast growth may be met by a progression factor together with the extracellular matrix serving both as a competence factor and as a site for attachment .
In this context, we have hypothesized that fibronectin, a glycoprotein component of the extracellular matrix with specific domains that bind to the fibroblast surface and to specific regions of various components of the extracellular matrix (13) (14) (15) , can act as a competence factor . This report demonstrates that fibronectin is a competence factor by two criteria : (a) the ability of fibronectin to promote fibroblast replication in a serum-free complementation test with known progression factors; and (b) the action of fibronectin early in the temporal sequence of G, .
MATERIALS AND METHODS

Preparation of Growth Factors
Plasma Fibronectin . Fibronectin was purified from human plasma by gelatin sepharose affinity chromatography as described by Engvall and Ruoslathti (16), followed by gel filtration . Briefly, 100 ml of peripheral blood were collected by venipuncture and anticoagulated with EDTA. Cells were separated from plasma by centrifugation, and the plasma was applied to a gelatinsepharose column . Fibronectin was eluted from the column with 6 M urea followed by further purification of a 5-ml aliquot of the peak concentration (-2 mg/ml) on a Sephadex G-150 column . The fibronectin content of each fraction was quantified by an enzyme-linked immunosorbent assay as previously described (17) . To reduce the probability that the fibronectin was contaminated by trace amounts of other growth factors found in plasma, some fibronectin preparations were purified by gelatin-sepharose followed by heparinagarose chromatography . The gelatin-sepharose column was eluted with 4 M urea, and the eluate was applied directly to a heparin-agarose column followed by elution with 0 .5 M NaCl in 60 mM Tris-HCI, pH 7 .4, 5 mM EDTA, as described by Hayashi and Yamada (18) .
All fibronectin samples were adjusted to a fibronectin concentration of -1 mg/ml with 8 M urea, and stored in aliquots in liquid nitrogen vapor. As needed, an aliquot of fibronectin was thawed, dialyzed 1 :500 against Dulbecco's modified Eagle medium (DME' ; Biofluids, Rockville, MD .) for two changes at 22°C . For each sample, fibronectin was quantified by an enzyme-linked immunosorbent assay following dialysis . Alveolar Macrophage Fibronectin : To purify alveolar macrophage fibronectin, --50 x 10 6 alveolar macrophages, obtained by bronchoalveolarlavage of patients with fibrotic lung disorders, were cultured for 24 h at 37°C in an atmosphere of 95% air-5% CO2 in RPMI 1640 medium (Biofluids) supplemented with penicillin (100 U/ml) and streptomycin (100 gg/ml) (19) . Resultant supernatants were dialyzed against 50 mM NaCl, 20 mM Tris HCI, pH 7 .4, 2 M urea, at 22°, and then chromatographed on DEAE cellulose (Whatman Laboratory Products, Inc ., Clifton, NJ) in the same buffer with a NaCl gradient from 50 to 300 mM . To identify the fractions containing fibronectin, an aliquot of each fraction was dialyzed (1 :500) against 150 mM NaCl, 20 mM Tris HCI, pH 7 .4, and fibronectin content was determined by an enzyme-linked immunosorbent assay . Fibronectin-containing fractions were stored in liquid nitrogen vapor. Prior to use in growth experiments, the DEAE-purified macrophage fibronectin was dialyzed 1 :500 against DME and assayed for fibronectin content by an enzyme-linked immunosorbent assay .
Alveolar Macrophage-derived Growth Factor (AMDGF) . AMDGF was purified from the supernatants of alveolar macrophages obtained by bronchoalveolar lavage of normal individuals as previously described (8) . The macrophages were activated by surface adherence and then cultured (24 h, 37°C) in DME supplemented with pencillin/streptomycin . The AMDGF was partially purified from the macrophage supernatants by ion exchange chromatography followed by gel filtration . Briefly, 600 ml of macrophage supernatants, containing 2 .1 mg of macrophage secretory protein (determined by a colorimetric assay [Bio-Rad Laboratories, Richmond CA) using BSA [Sigma Chemical Co., St . Louis, MOI as a standard), was chromatographed on DEAE cellulose and eluted at 4°C with a NaCI gradient (150-300 mM) buffered with 20 mM Tris-HCI, pH 7 .0 . The peak of bioactivity (at -270 mM) was detected by its ability to promote the replication of human lung frbroblasts (8) . This peak was lyophilized, resuspended in PBS, then chromatographed on Sephadex G-50 in PBS, pH 7 .4, at 4°C . The peak of activity eluted at 18,000 daltons, and was stored in liquid nitrogen vapor at a concentration of 1 .2 Ag/ml . Serial dilutions 'Abbreviations used in this paper: AMDGF, alveolar macrophagederived growth factor ; DME, Dulbecco's modified Eagle medium ; FGF, fibroblast growth factor ; PDGF, platelet-derived growth factor .
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Other Growth Factors: Pituitary fibroblast growth factor (FGF) was obtained from Collaborative Research Inc . (Waltham, MA) and insulin from Sigma Chemical Co . Platelet-derived growth factor (PDGF) was partially purified as described by Vogel et al . (20) .
Evaluation of Plasma Fibronectin as a Growth Factor
All experiments were performed on HFL-1 fibroblasts (American Type Culture Collection CCL 153), previously frozen in liquid nitrogen vapor at the tenth to twelfth population doubling. Cells were cultivated on 100-mm tissue culture dishes (Falcon Labware, Cockeysville, MD) in DME supplemented with 10% calf serum (Colorado Serum, Denver, CO) as previously described (21) , and used for growth studies between the fifteenth and twentieth population doubling.
To evaluate the effect of plasma fibronectin on fibroblast replication in a defined medium, the complementation test of Stiles et al . (7) was adapted for serum-free conditions. To accomplish this, fibroblasts were cultured on 35-mm dishes (Falcon Labware, 5 x 10' cells/dish) in DME plus 0.4% serum for 3 d. Cells were then rinsed three times with serum-free DME followed by cultivation for 1 d in "complementation test medium" (DME + 5,ug/ml transferrin (Sigma Chemical Co . plus 0.1 % BSA [Sigma catalogue 78881). Under these conditions, fibroblasts did not replicate without subsequent addition of growth factors. For convenience, fibroblasts cultured for 3 d in serum-free DME + 0.4% serum followed by culture for 1 d in "complementation test medium" will be referred to as nonreplicating fibroblasts .
The basic principle of the complementation test is that nonreplicating fibroblasts require both a competence factor and a progression factor for an optimal replication rate . Thus, to evaluate the role of plasma fibronectin as a growth factor, fibronectin was added to cultures of nonreplicating fibroblasts in combination with either a characterized competence factor (FGF) or a characterized progression factor (insulin or AMDGF), and fibroblast growth was assessed . To accomplish this, complementation test medium containing each growth factor individually or plasma fibronectin in combination with either FGF, insulin, or AMDGF (at the concentrations indicated in the text) was placed on nonreplicating fibroblasts, and the cultures were continued at 37°C . Cell counts were determined daily for 4 d with an electronic particle counter (Coulter Electronics, Hialeah, FL). Cell counts in complementation test medium alone served as negative controls. As a positive control, in each experiment FGF was added to nonreplicating fibroblasts with either insulin or AMDGF to verify a synergistic increase in cell number.
Since Clemmons (22) has demonstrated that confluent fetal frbroblasts can release their own competence factor(s), the nonreplicating HFL-I cells at low density used for the bioassay were evaluated for production of competence factor(s) that might obscure the effect of exogenously added growth factors . To accomplish this, frbroblasts were seeded at low density in DMEM plus 0.4% serum for 3 d and rinsed as described above, then cultured in complementation test medium for 1, 2, 3, or 4 d, and the "conditioned medium" was collected each day . Culture of nonreplicating frbroblasts (37°C, 3-5 d) with conditioned medium (undiluted, 1 :2, 1 :4, 1 :8) alone, or supplemented with insulin (10,ug/ ml) or AMDGF (10 ng/ml), caused no increase in cell number above control. Thus, under the conditions used, exogenously added factors were necessary to provide competence .
One potential problem with attributing growth-promoting properties to fibronectin was the possibility that the preparation was contaminated with small amounts of PDGF. Since PDGF is heat stable (23), a fibronectin preparation (I gg/ml) with or without supplemental PDGF (100 ng/ml), was boiled (100°C, 10) min) and then evaluated in a complementation test as described above .
To determine the effect of plasma fibronectin on the replication of fibroblasts that had been growth arrested by density inhibition rather than serum deprivation, confluent monolayers of frbroblasts were cultured with growth factors and the effect on DNA synthesis was assessed. To accomplish this, frbroblasts were seeded (5 x 10'/well in 0.25 ml DME plus 10% calf serum) onto 8-well glass slides (Lab-Tek, Miles Laboratories, Naperville IL) and cultured in DME plus 10% calf serum with the medium changed every other day until the cells were confluent and no mitotic cells were observed by phase contrast microscopy. The confluent cells were cultured one additional day without a medium change, rinsed three times with serum-free DME, and then cultured (30 h, 37°C) in complementation test medium containing 0.1 uCi/ml ['H)thymidine (2 Ci/mMol, Amersham Corp., Arlington Heights, IL) plus each growth factor individually, or both a competence factor (PDGF, FGF, or fibronectin at the concentrations indicated in the text) and a progression factor (AMDGF, 10 ng/ ml or insulin, 10 kg/ml) . After this interval, cells were fixed in methanol:acetic acid (3 :1) and processed for autoradiography was previously described (8) . DNA synthesis in complementation medium alone served as a control. Each condition was performed in quadruplicate with >200 nuclei counted per well.
Evaluation of Macrophage Fibronectin as a Growth Factor
Because of the difficulty of preparing sufficient amounts of macrophage fibronectin to perform the cell counting assay, the ability of macrophage fibronectin to act as a growth factor for fibroblasts was studied in a microassay using DNA synthesis rather than cell number as an index of fibroblast replication . The complementation test was performed in a way analogous to that described above except that the nonreplicating fibroblasts were cultured in microtiter wells (10`fibroblasts/well, 96-well plates; Falcon Labware) in 0 .2 ml of complementation test medium with or without exogenous growth factors . After a 14-h incubation at 37°C, each well was pulsed with ['H]thymidine (0 .1 t,Ci/ml ; 2 Ci/mMol, Amersham Corp.). After an additional 24-h incubation, acid-precipitable ['H]thymidine incorporation was determined by scintillation counting. ['H]Thymidine incorporation in the absence of added growth factors (I 100 .h 300 dpm/ 10' fibroblasts) was subtracted from the values in the presence of growth factors to correct for the ['H]thymidine incorporation unrelated to growth factor addition .
Ability of Fibronectin to Signal Fibroblasts to Respond to Progression Factors
To evaluate the ability of fibronectin to signal fibroblasts to replicate in response to signals from progression factors, plasma fibronectin was added to fibroblasts suspended in complementation test medium at the time of seeding and then removed prior to addition of progression factors. To accomplish this, 35-mm tissue culture dishes were coated with collagen (prepared from lathyritic rat skins, the gift of H . K. Kleinman, National Institute of Dental Research) as previously described, and sterilized by exposure to ultraviolet irradiation . Fibroblasts were prepared by incubation with trypsin (Gibco Laboratories, Grand Island, NY 0 .25% ; 1 min, 22°C) to detach them from culture dishes, washed once in DME plus soybean trypsin inhibitor to inactivate the trypsin, washed three times in complementation test medium, and resuspended in that same medium in the presence or absence of plasma fibronectin (1 .0 ag/ml) . Fibroblasts with or without added fibronectin were then seeded at a density of 5 x 10' cells/collagen-coated dish . After incubation overnight (14 h, 37C), the fibroblasts were rinsed three times with DME to remove unbound fibronectin . Cell counts were then determined to confirm equal plating efficiency . The fibroblasts were then cultured for three d with either FGF, insulin, or AMDGF at the concentrations indicated . At the end of the 3-d culture, the number of cells was counted to determine the growth response.
Cell Cycle Kinetics
Previous studies have indicated that competence factors act early in the G, phase of the cell cycle of nonreplicating BALB/C 3T3 cells (5) . To determine where, in the temporal sequence of G I , fibronectin provided its growth-promoting signal to lung fibroblasts, the kinetics of fibroblast DNA synthesis after pretreatment with fibronectin was determined . Nonreplicating fibroblasts (10" cells/well, Falcon 96-well microtiter dishes, 0 .2 ml of complementation test medium per well) were cultured for 12 h with (a) no further additions; (b) fibronectin (1 .0 kg/ml) ; or (c) FGF (2 ng/ml). Following this 12-h incubation, calf serum was added to a final concentration of 10% (i.e., to provide the fibroblasts with a complete set of signals to replicate and thus to determine whether the pretreatment with fibronectin shifted the time of onset of DNA synthesis) . ['H]Thymidine (0.5 1ACi/ml, 2 Ci/mMol, Amersham Corp.) was added with the serum . At the time of serum and ['H]thymidine addition, and every 2 h for the subsequent 18 h, triplicate wells of fibroblasts were harvested for measurement of acid-precipitable ['H]thymidine incorporation . To establish the background for each time point in the assay, triplicate wells of fibroblasts were pretreated as described above and then cultured with ['H]thymidine but without serum . The background was then subtracted from the experimental time points . These background values ranged from 200 .t 75 dpm/10" cells at 2 h to 900 ± 125 dpm/10`cells at 18 h .
Statistical Evaluation
Each condition for the cell counting experiments was performed in duplicate, with replicates varying by <7% . Each condition in the ['H]thymidine incorporation experiments was performed in triplicate . Experimental values were compared using a two-tailed Student's t-test . The data presented are the mean ± standard deviation of three experiments using fibroblasts with nearly identical tissue-culture histories.
RESULTS
Fibroblast Replication in Response to Plasma Fibronectin
Nonreplicating lung fibroblasts cultured in complementation test medium containing fibronectin and insulin were stimulated to replicate (Fig. 1) . When fibroblasts were cultured for 3 d in DME plus 0.4% serum followed by 1 d in complementation test medium, they entered a nonreplicating state, maintaining constant cell numbers for an additional 5 dunless growth factors were added. In the example shown, cultivation of the nonreplicating fibroblasts for 5 d in complementation test medium maintained cell number at 15 x 104 fibroblasts/ dish. Each growth factor individually caused less than a 20% increase in cell number by the fifth day after growth factor addition (data not shown) . The addition of fibronectin (0.2 Wg/ml) and a competence factor (FGF, 1 .0 ng/ml) to the nonreplicating fibroblasts resulted in only a slight stimulation offibroblast replication, suggesting that fibronectin was not a progression factor. Within 2 d there were 17 x 104 cells/dish, and by the fifth day after growth factor addition there were 18 x 10°cells/dish, only a 20% increase in cell number. In contrast, the addition of fibronectin (0.2 kg/ml) and progression factor (insulin, 5 Ag/ml) to nonreplicating fibroblasts markedly stimulated fibroblast replication, suggesting that fibronectin was a competence factor . In this regard, there were 32 x 10°cells/dish by the fifth day after growth factor addition, representing an 110% increase in cell number . Nonreplicating fibroblasts cultured in complementation test medium manifested a dose-dependent increase in replication rate in response to fibronectin only when a progression factor (i.e., insulin or AMDGF) was also present (Fig. 2) . The addition of fibronectin alone to the fibroblast cultures resulted in a modest increase in cell number. Furthermore, the addition of fibronectin and a fixed dose of a competence factor (FGF, 2.0 ng/ml) to the fibroblast cultures resulted in little further increase in cell number . In contrast, the addition of fibronectin along with a fixed dose of a progression factor (either insulin [ 10 Wg/ml] or AMDGF, [ 10 ng/ml]) resulted in a marked increase in cell number up to -170% above control with a fibronectin concentration of 2.0 ug/ml. This pattern of growth-promoting activity indicated that fibronectin acted as a competence factor .
In view of these findings, it was important to demonstrate that the dose-dependent competence signal provided by fibronectin was due to the fibronectin itself and not a contaminant of the fibronectin preparation . To exclude the possibility that part of the observed growth response was due to a contaminant of the fibronectin preparation, fibronectin was purified by two methods : gelatin-sepharose affinity chromatography followed by (a) gel filtration chromatography ; or (b) heparinagarose affinity chromatography . The results with both preparations were identical, suggesting that fibronectin and not a contaminant was responsible for the growth-promoting effect. Dose dependence of the stimulation of fibroblast replication by plasma fibronectin. Nonreplicating fibroblasts were cultured with increasing amounts of fibronectin and either a progression factor or a competence factor. The resultant increase in fibroblast number is expressed as the percent increase in cell number above control. Shown is the effect of fibronectin on fibroblast replication alone (p); in the presence of the progression factor AMDGF (10 ng/ml, E) ; in the presence of the progression factor insulin (10 Ag/ml, 4p); or in the presence of the competence factor FGF (2 .0 ng/ml, A) .
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THE JOURNAL OF CELL BIOLOGY " VOLUME 97, 1983 In addition, to rule out the possibility that PDGF (a heatstable competence factor with high positive charge) might still be contaminating the preparation, the heat stability of the fibronectin-induced growth response was assessed. Boiling the fibronectin resulted in complete loss of activity in the assay described above. Supplementing the fibronectin with authentic PDGF (100 ng/ml) followed by boiling resulted in that amount of fibroblast growth observed with unboiled PDGF (data not shown) . Therefore, contamination ofour fibronectin with PDGF did not account for the growth-promoting effects observed.
Fibronectin not only provided a competence signal to fibroblasts that had been growth arrested at low density by serum deprivation, but also provided a dose-dependent competence signal to fibroblasts arrested in GI by culture to saturating density (Table I) . When confluent fibroblasts were cultured with the characterized competence factors, PDGF or FGF, in the presence of a progression factor (AMDGF, 10 ng/ml or insulin, 10 fig/ml) there was a dose-dependent increase in DNA synthesis . The maximum response ranged from 26 to 33% labeled nuclei representing -50 to 75% of the DNA synthesis produced by the addition of 10% calf serum. Similarly, the addition of fibronectin to the densityarrested fibroblasts in the presence of either AMDGF or insulin resulted in a significant though smaller increase in fibroblast DNA synthesis (p < .01, compared with media alone). The maximum DNA synthesis in response to fibronectin was 16% labeled nuclei representing about one-third ofthe response to 10% calfserum. In contrast, DNA synthesis in response to each factor individually was far less, ranging from 1 to 7% . In addition, only for PDGF and FGF individually was there a small dose-related increase in nuclear labeling.
Fibroblast DNA Synthesis in Response to Macrophage Fibronectin
When nonreplicating fibroblasts were incubated in the presence of a progression factor there was an increase in the rate 30 h, 37°C ; mean ± SD of three experiments. In the presence of medium + 10% calf serum, the percent nuclei labeled = 45 ± 6%. = Insulin = 10 jug/mi . s AMDGF = 10 ng/ml. of DNA synthesis in response to increased amounts of macrophage fibronectin (Fig. 3) . As observed with plasma fibronectin, there was a macrophage fibronectin dose-dependent increase in the fibroblast growth response in the presence of either insulin (10 ug/ml) or AMDGF (10 ng/ml). The result was similar to that observed when [3H]thymidine incorporation was used as the index of fibroblast replication in response to plasma fibronectin in the presence of AMDGF or insulin (data not shown) . Comparison of the dose-response relationships between macrophage fibronectin and plasma fibronectin revealed that 50% of the maximum response occurred within a twofold concentration range of fibronectin (80 ± 15 ng/ml for macrophage fibronectin and 200 ± 23 ng/ml for plasma fibronectin), indicating that there was not a major difference in growth-promoting potency of the fibronectins from these two different sources. Thus, both plasma and macrophage fibronectin provided a dose-dependent competence signal for lung fibroblasts.
Ability of Fibronectin to Signal fibroblasts to Respond to Progression Factors
Nonreplicating fibroblasts seeded onto collagen-coated dishes in the presence of fibronectin manifested a rapid rate of replication after the addition of a progression factor (Fig.  4) . Under the conditions used, fibroblasts seeded onto collagen-coated dishes in complementation test medium had similar plating efficiencies in the absence or presence of exogenous fibronectin (1 .0 ug/ml) . When fibroblasts were allowed to adhere in the absence of fibronectin, they did not replicate when a progression factor (insulin or AMDGF) was added. In marked contrast, when fibroblasts were allowed to adhere in the presence of fibronectin, there was a dose-related increase in replication rate after addition of insulin or AMDGF . For example, at an insulin concentration of 5 ug/ml, cell number increased 93% above control and at 50 Ag/ml cell number increased 125% above control. Addition of AMDGF resulted in a similar stimulation of cell replication, with an 80% increase in cell number above control at a concentration of 0.1 ng/ml and a 140% increase at an AMDGF concentration of 10 ng/ml . Thus, fibronectin was able to provide a signal to fibroblasts that allowed them to replicate in response to a progression signal .
Further confirmation that the growth-promoting effect of Dose dependence of the stimulation of fibroblast DNA synthesis by macrophage fibronectin. Nonreplicating fibroblasts were cultured with increasing amounts of fibronectin and a progression factor . Shown is fibroblast DNA synthesis in response to fibronectin alone ( "), or in the presence of the progression factors insulin (10 jug/ml, /), or AMDGF (10 ng/ml, O) . Ability of plasma fibronectin to signal fibroblasts to respond to progression factors . Fibroblasts in suspension culture were added to collagen-coated dishes in the presence or absence of fibronectin (1 .0 ug/ml) and then cultured for 14 h. The plates were rinsed three times to remove unbound fibronectin, exposed to different concentrations of progression factors in fresh complementation test medium, and the cultures continued for an additional three days . Resultant effects on fibroblast growth are expressed as the percent increase in cell number above control. (A) Growth of fibroblasts in the presence of the progression factor insulin : O, cells exposed to fibronectin prior to insulin addition ; ", no fibronectin exposure prior to insulin addition . (ß) Growth of fibroblasts in the presence of the progression factor alveolar macrophage-derived growth factor (AMDGF) with (O) or without (0) prior exposure to fibronectin . (C) Growth of fibroblasts in the presence of the competence factor fibroblast growth factor (FGF) with (O) or without (0) prior exposure to fibronectin . fibronectin for fibroblasts was not due to a progression signal was provided by the absence of a dose-related increase in fibroblast replication in the presence of FGF, a known competence factor (Fig. 4 C) . Seeding fibroblasts in the presence of fibronectin did not enable FGF to substantially augment their rate of replication compared with fibroblasts seeded in the absence offibronectin, suggesting that fibronectin was not providing a progression signal. As a positive control, fibroblasts exposed to FGF (1-2.5 ng/ml) in the presence ofinsulin (5 ug/ml) or AMDGF (10 ng/ml) demonstrated a significant increase in fibroblast replication, an effect that was not substantially augmented by the addition of fibronectin (1 .0 ug/ ml) to the cultures (data not shown).
Evaluation of the Position of Action of Fibronectin in the G, Phase of the Cell Cycle
Evaluation of the timing of DNA synthesis under various conditions demonstrated that fibronectin acted as a competence factor by providing a growth-promoting signal early in G, (Fig. 5) . Under the conditions used in these studies, without the addition ofgrowth factors, nonreplicating lung fibroblasts were arrested in the G, phase of the cell cycle, about 12-14 h before the onset of S phase. Nonreplicating fibroblasts cultured for 12 h with the competence factor FGF (2.0 ng/ml) traversed about one-third of the remaining interval of G,, arresting 8-10 h from S phase . Within the framework of this temporal sequence of G,, fibronectin (1 .0 ug/ml) also signalled nonreplicating fibroblasts to traverse one-third of G,, with DNA synthesis beginning 8-10 h after serum addition . In contrast, incubation of fibroblasts for 12 h with insulin or AMDGF prior to the addition of serum resulted in no traversal of G,, i.e., there was still a 12-14-h lag for DNA synthesis, a value similar to that for cells in complementation test medium alone (data not shown). FIGURE 5 Effect of plasma fibronectin on the cell cycle kinetics of nonreplicating fibroblasts . Nonreplicatíng fibroblasts were cultured for 12 h with or without added growth factors followed by addition of serum and ['Hlthymidine . Shown is ['Hlthymidine incorporation into DNA by fibroblasts pretreated for 12 h with complementation test medium alone (p), fibronectin (*; 1 .0 ug) ; or FGF (p ; 2 .0 ng/ ml) . Data are expressed as disintegrations per minute per 10" cells as a function of time after addition of serum .
DISCUSSION
Fibronectin, at concentrations in the nanomolar range, can, under the appropriate circumstances, stimulate nonreplicating human lung fibroblasts to replicate in a dose-dependent manner. In this context, fibronectin is able to complement the growth-promoting effects ofthe characterized progression factors, insulin and AMDGF, by providing a competence signal to nonreplicating fibroblasts . In providing this competence signal, fibronectin stimulates nonreplicating fibroblasts to traverse G,^-4 to 6 h. Thus, at least for diploid human fibroblasts, replication can be induced in serum-free conditions by a signal from the extracellular matrix component, fibronectin, plus an additional signal provided by a progression factor .
Role of Extracellular Matrix in Growth Control
There are several lines of evidence that extracellular matrix elements can provide growth promoting signal(s) to parenchymal cells. For example, in addition to stimulating the replication of human lung fibroblasts as shown in the present study, fibronectin augments the replication rate ofchick heart fibroblasts (24) and human dermal fibroblasts (25) . In addition, type IV collagen, a basement membrane component intimately associated with the basal surface of epithelial cells, promotes the replication of rat mammary epithelial cells (26) . Furthermore, bovine corneal endothelial extracellular matrix, a highly ordered collection of several matrix elements, promotes the replication ofbovine vascular endothelial cells (10) . Thus, extracellular matrix components have a role in attaching and orienting parenchymal cells within an organ, and in addition there is increasing evidence that at least some of these components are able to provide a signal for cellular replication . can mediate cell attachment and spreading (27, 28) , three lines of evidence suggest that fibronectin provides a signal that stimulates cell replication beyond its ability to mediate attachment and spreading, i.e., fibronectin is able to provide a competence signal directing cell replication that is not provided by the process of attachment and spreading .
First, under the conditions employed in this study, normal human lung fibroblasts attached to collagen-coated dishes in equal numbers in the presence or absence of exogenous fibronectin . However, only fibroblasts exposed to exogenously added fibronectin were competent to replicate in response to progression factors . This finding suggests that attachment alone, perhaps mediated by endogenously produced fibronectin, by residual cell surface fibronectin, or by other cell surface components (29) , is not sufficient to confer responsiveness to progression factors.
Second, consistent with our observations, Hall and Gangùly (25) have shown that, in serum-free medium, dermal fibroblasts attach to tissue culture plastic but do not replicate. However, the addition to plasma fibronectin to these attached cells promotes both spreading and replication in a dosedependent manner. While this observation does not dissociate the effects of fibronectin on spreading and replication, it clearly provides further evidence that attachment is not sufficient to promote fibroblast replication .
Third, dissociation of the effect of fibronectin on cell spreading from the competence signal for replication is provided by our observation that fully spread lung fibroblasts cultured for several days but not exposed to fibronectin are unresponsive to progression factors. However, when exogenous fibronectin is added, the fibroblasts respond to the progression factors and replicate .
Mechanisms of Modulation of Cellular Replication by the Extracellular Matrix
For the process of fibroblast replication, the dual control model ofPledger and co-workers (6) suggests that most growth factors can be classified as competence factors or progression factors according to their position of action within the temporal sequence of G,. Although this is still a working model that has not been completely validated, it emphasizes the importance of cell cycle specific signals in the control of cell replication and thus provides a useful framework in which to conceptualize growth signals . Competence factors, such as FGF, act early in G, and need be present for only a few hours to render a cell responsive to a subsequent progression signal . Progression factors, such as the insulin-like growth factors and AMDGF, provide a signal later in G, that, under the appropriate conditions, allows the cell to proceed to DNA synthesis . In this model, both a competence signal and a progression signal are necessary for significant cell replication (7, 30) .
While the precise mechanisms of action of either competence or progression factors are not known, in principle, they may act directly by initiating the sequence of events leading to replication, or indirectly by stimulating the target cell to produce their own growth factors . With regard to progression factors, several defined signals are capable of stimulating human fibroblasts to produce insulin-like growth factors (31, 32) , which are active at nanomolar concentrations as progression factors . Evaluation for an analogous inducible production of competence factors by fibroblasts has not been described . However, Clemmons (22) has demonstrated that confluent monolayers of human fibroblasts release competence factor(s) into the medium constitutively . This raises the theoretical consideration that nonreplicating fibroblasts (low density or confluent) might be signalled to divide by a growth factor that stimulates the target cell to produce its own competence factor.
Within this framework, the present study demonstrates that fibronectin acts as a competence factor by providing a signal early in G1, either directly or indirectly, permitting human lung fibroblasts to proliferate in response to progression factors. Fibronectin provides this competence signal to fibroblasts that have been arrested in G, either by serum deprivation or by growth to saturating densities . However, while fibronectin is as potent as the well characterized competence factors FGF and PDGF with regard to stimulating the replication of fibroblasts arrested by serum deprivation, it clearly was not so potent as FGF or PDGF in stimulating DNA synthesis by density-arrested fibroblasts. This difference in potency, depending upon the method used to arrest fibroblasts in G,, distinguishes fibronectin from other competence factors such as FGF or PDGF.
While the applicability of the dual control model has not been directly assessed in cells other than fibroblasts, the concept that extracellular matrix can provide a specific signal for cellular replication is also in accord with the work of Gospodarowicz and Ill (10) . These workers demonstrated that the requirement of bovine vascular endothelial cells for the competence factor, FGF, was eliminated by culturing these cells on an extracellular matrix produced by bovine corneal endothelial cells. Interestingly, however, in contrast to the situation with lung fibroblasts, fibronectin does not provide a good competence signal to vascular endothelial cells when compared with intact extracellular matrix. Together, these observations are consistent with the concept that matrix components provide a competence signal but that different cell types may require different matrix components.
Although the signal provided by fibronectin in stimulating lung fibroblast growth acts early in G1 , the growth-promoting actions of fibronectin may occur at other times in the cell cycle for other cells. In this context, Orly and Sato (33) have demonstrated a marked increase in rat follicular cell replication in serum-free medium containing fibronectin, transferrin, and insulin; analysis of the cell cycle specificity of the growth-promoting signal provided by fibronectin demonstrated that it was required for cytokinesis during M phase. Thus, for various types of cells, fibronectin can serve an important function in the control of replication, but these functions may be cell specific.
Various Roles for Fibronectin in Tissue Reconstruction and Fibrosis
The present study demonstrates that both plasma fibronectin and macrophage fibronectin can provide a replication signal to fibroblasts . Together with the known functions of fibronectin in promoting fibroblast chemotaxis (34) (35) (36) and attachment and spreading (27, 28) , these observations suggest a fundamental role for fibronectin in the reparative processes following injury. For example, in wound healing where capillary leak is significant and macrophages play an important role (37) , plasma fibronectin as well as macrophage fibronectin may contribute in concert with other growth factors to the increase in fibroblast numbers characteristic of this process. Furthermore, in human fibrotic lung disease, alveolar macrophages are releasing both fibronectin (34) and AMDGF (38) , factors that, together, can recruit fibroblasts (fibronectin), attach fibroblasts (fibronectin), and signal replication of fibroblasts (fibronectin and AMDGF) . Consistent with this concept, morphologic studies of the alveolar wall in these diseases have demonstrated increased numbers of fibroblasts (39) . Thus fibronectin may by one of the stimuli that results in expansion of the fibroblast population in various physiological and pathological settings.
